Your browser doesn't support javascript.
loading
Glycogen Synthase Kinase-3ß as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar, Manoj P; Valvassori, Samira S; Dal-Pont, Gustavo C; Quevedo, Joao.
Afiliação
  • Dandekar MP; Translational Psychiatry Program, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Houston, TX, United States.
  • Valvassori SS; Laboratory of Neuronal Signaling and Psychopharmacology, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil.
  • Dal-Pont GC; Laboratory of Neurosciences, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil.
  • Quevedo J; Laboratory of Neuronal Signaling and Psychopharmacology, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil.
Curr Drug Metab ; 19(8): 663-673, 2018.
Article em En | MEDLINE | ID: mdl-29283064
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Transdução de Sinais / Inibidores de Proteínas Quinases / Glicogênio Sintase Quinase 3 beta / Neurônios Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Transdução de Sinais / Inibidores de Proteínas Quinases / Glicogênio Sintase Quinase 3 beta / Neurônios Idioma: En Ano de publicação: 2018 Tipo de documento: Article